PubMed listed publications – Urology
Lithotripsy
Does Stepwise Voltage Ramping Protect the Kidney from Injury During Extracorporeal Shockwave Lithotripsy? Results of a Prospective Randomized Trial.
Skuginna, V; Nguyen, DP; Seiler, R; Kiss, B; Thalmann, GN; Roth, B.
Eur Urol. 2016 Feb;69(2):267-73
PMID: 26119561 [Indexed for MEDLINE]
The feasibility of shockwave lithotripsy for treating solitary, lower calyceal stones over 1 cm in size.
Kim, TB; Lee, SC; Kim, KH; Jung, H; Yoon, SJ; Oh, JK.
Can Urol Assoc J. 2013 Mar-Apr;7(3-4):E156-60.
PMID: 23589749 [PubMed – indexed for MEDLINE]
Residual fragments following ureteroscopic lithotripsy: incidence and predictors on postoperative computerized tomography.
Rippel, CA; Nikkel, L; Lin, YK; Danawala, Z; Olorunnisomo, V; Youssef, RF; Pearle, MS; Lotan, Y; Raman, JD.
J Urol. 2012 Dec;188(6):2246-51.
PMID: 23083650 [Indexed for MEDLINE]
Evaluation of shock wave lithotripsy injury in the pig using a narrow focal zone lithotriptor.
Connors, BA; McAteer, JA; Evan, AP; Blomgren, PM; Handa, RK; Johnson, CD; Gao, S; Pishchalnikov, YA; Lingeman, JE.
BJU Int. 2012 Nov;110(9):1376-85.
PMID: 22519983 [Indexed for MEDLINE]
Risk factors for perinephric hematoma formation after shockwave lithotripsy: a matched case-control analysis.
Razvi, H; Fuller, A; Nott, L; Méndez-Probst, CE; Leistner, R; Foell, K; Davé, S; Denstedt, JD.
J Endourol. 2012 Nov;26(11):1478-82.
PMID: 22712655 [Indexed for MEDLINE]
Factors determining stone-free rate in shock wave lithotripsy using standard focus of Storz Modulith SLX-F2 lithotripter.
Elkoushy, MA; Hassan, JA; Morehouse, DD; Anidjar, M; Andonian, S.
Urology. 2011 Oct;78(4):759-63.
PMID: 21550641 [Indexed for MEDLINE]
The lithotripsy table height: a novel predictor of outcome in shockwave lithotripsy.
Ossandon, E; Recabal, P; Acevedo, C; Flores, JM; Marchant, F.
Int Braz J Urol. 2011 May-Jun;37(3):355-61.
PMID: 21756383 [Indexed for MEDLINE]
A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter.
Zehnder, P; Roth, B; Birkhäuser, F; Schneider, S; Schmutz, R; Thalmann, GN; Studer, UE.
Eur Urol. 2011 Apr;59(4):637-44.
PMID: 21296481 [Indexed for MEDLINE]
[A single center experience with a lithotripsy machine “Modulith SLX-F2” : evaluation of dual focus system and clinical results].
Suzuki, K; Yamashita, Y; Yoshida, M; Matuzaki, J.
Hinyokika Kiyo. 2010 Feb;56(2):81-6.
PMID: 20185991 [Indexed for MEDLINE]
How efficient is extracorporeal shockwave lithotripsy with modern lithotripters for removal of ureteral stones?
Tiselius HG.
J Endourol. 2008 Feb;22(2):249-55.
PMID: 18294029 [Indexed for MEDLINE]
In vitro comparison of shock wave lithotripsy machines.
Teichman, JM; Portis, AJ; Cecconi, PP; Bub, WL; Endicott, RC; Denes, B; Pearle, MS; Clayman, RV.
J Urol. 2000 Oct;164(4):1259-64.
PMID: 10992376 [Indexed for MEDLINE]
CPPS/IPP/ED
Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie’s disease, erectile dysfunction and chronic pelvic pain.
Fojecki, GL; Tiessen, S; Osther, PJ.
World J Urol. 2017 Jan;35(1):1-9.
PMID: 27108421 [Indexed for MEDLINE]
Low-intensity Extracorporeal Shock Wave Treatment Improves Erectile Function: A Systematic Review and Meta-analysis.
Lu, Z; Lin, G; Reed-Maldonado, A; Wang, C; Lee, YC; Lue, TF.
Eur Urol. 2017 Feb;71(2):223-233.
PMID: 27321373 [Indexed for MEDLINE]
Low-intensity extracorporeal shockwave therapy in the treatment of postprostatectomy erectile dysfunction: a pilot study.
Frey, A; Sønksen, J; Fode, M.
Scand J Urol. 2016;50(2):123-7.
PMID: 26493542 [Indexed for MEDLINE]
Erectile function after radical prostatectomy: Do patients return to baseline?
Fode, M; Frey, A; Jakobsen, H; Sønksen, J.
Scand J Urol. 2016 Jun;50(3):160-3.
PMID: 26539834 [Indexed for MEDLINE]
Peyronie’s disease and low intensity shock wave therapy: Clinical outcomes and patient satisfaction rate in an open-label single arm prospective study in Australian men.
Chung, E.
Korean J Urol. 2015 Nov;56(11):775-80.
PMID: 26568796 [Indexed for MEDLINE]
Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial.
Chung, E; Cartmill, R.
BJU Int. 2015 Apr;115 Suppl 5:46-9.
PMID: 25828173 [Indexed for MEDLINE]
Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study.
Olsen, AB; Persiani, M; Boie, S; Hanna, M; Lund, L.
Scand J Urol. 2015;49(4):329-33.
PMID: 25470423 [Indexed for MEDLINE]
Novel treatment of chronic perineal pain in a woman by extracorporeal shock wave therapy: a case report and published work review.
Tung, CW; Cheon, WC; Tong, A.
J Obstet Gynaecol Res. 2015 Jan;41(1):145-8.
PMID: 25164767 [Indexed for MEDLINE]
Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial.
Vahdatpour, B; Alizadeh, F; Moayednia, A; Emadi, M; Khorami, MH; Haghdani, S.
ISRN Urol. 2013 Aug 28;2013:972601.
PMID: 24000311 [Indexed for MEDLINE]
Extracorporeal shock wave treatment for non-inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham-controlled study.
Zeng, XY; Liang, C; Ye, ZQ.
Chin Med J (Engl). 2012 Jan;125(1):114-8.
PMID: 22340476 [Indexed for MEDLINE]
A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie’s disease.
Palmieri, A; Imbimbo, C; Longo, N; Fusco, F; Verze, P; Mangiapia, F; Creta, M; Mirone, V.
Eur Urol. 2009 Aug;56(2):363-9.
PMID: 19473751 [Indexed for MEDLINE]
Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study.
Zimmermann, R; Cumpanas, A; Miclea, F; Janetschek, G.
Eur Urol. 2009 Sep;56(3):418-24.
PMID: 19372000 [Indexed for MEDLINE]
Low-energy extracorporeal shock wave therapy for chronic pelvic pain syndrome: finally, the magic bullet?
Marszalek, M; Berger, I; Madersbacher, S.
Eur Urol. 2009 Sep;56(3):425-6.
PMID: 19362412 [Indexed for MEDLINE]
Extracorporeal shock-wave therapy for treating chronic pelvic pain syndrome: a feasibility study and the first clinical results.
Zimmermann, R; Cumpanas, A; Hoeltl, L; Janetschek, G; Stenzl, A; Miclea, F.
BJU Int. 2008 Sep;102(8):976-80.
PMID: 18510660 [Indexed for MEDLINE]
The impact of shock wave therapy at varied energy and dose levels on functional and structural changes in erectile tissue.
Müller, A; Akin-Olugbade, Y; Deveci, S; Donohue, JF; Tal, R; Kobylarz, KA; Palese, M; Mulhall, JP.
Eur Urol. 2008 Mar;53(3):635-42.
PMID: 17618733 [Indexed for MEDLINE]
Extracorporeal shock-wave therapy for treating chronic pelvic pain syndrome: a feasibility study and the first clinical results.
Zimmermann, R; Cumpanas, A; Hoeltl, L; Janetschek, G; Stenzl, A; Miclea, F.
BJU Int. 2008 Sep;102(8):976-80.
PMID: 18510660 [Indexed for MEDLINE]
Nonsurgical management of Peyronie’s disease–are we making any progress?
Meacham, RB.
J Urol. 2006 Jul;176(1):12-3.
PMID: 16753356 [Indexed for MEDLINE]
Extracorporeal shockwave therapy for Peyronie’s disease: who benefits?
Taylor, J; Forster, JA; Browning, AJ; Biyani, CS.
J Endourol. 2006 Feb;20(2):135-8.
PMID: 16509800 [Indexed for MEDLINE]
[Assessment among German urologists of various conservative treatment modalities for Peyronie’s disease. Results of a survey].
Hauck, EW; Bschleipfer, T; Haag, SM; Rohde, V; Weidner, W.
Urologe A. 2005 Oct;44(10):1189-92, 1193-6.
PMID: 16044283 [Indexed for MEDLINE]
Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men.
Anderson, RU; Wise, D; Sawyer, T; Chan, C.
J Urol. 2005 Jul;174(1):155-60.
PMID: 15947608 [Indexed for MEDLINE]
Extracorporeal shock wave therapy for Peyronie’s disease: exploratory meta-analysis of clinical trials.
Hauck, EW; Mueller, UO; Bschleipfer, T; Schmelz, HU; Diemer, T; Weidner, W.
J Urol. 2004 Feb;171(2 Pt 1):740-5.
PMID: 14713800 [Indexed for MEDLINE]
Objective and subjective changes in patients with Peyronie’s disease after management with shockwave therapy.
Michel, MS; Ptaschnyk, T; Musial, A; Braun, P; Lenz, ST; Alken, P; Köhrmann, KU.
J Endourol. 2003 Feb;17(1):41-4; discussion 44.
PMID: 12639361 [Indexed for MEDLINE]